| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |